Skip to main content
Premium Trial:

Request an Annual Quote

Lisa Kuuttila, Augustine Cheng, Paul Silber

Lisa Kuuttila has been reappointed as president and CEO of STC.UNM, a subsidiary of the University of New Mexico responsible for the school’s technology transfer efforts.
Kuuttila rejoins STC.UNM effective June 11 from MSU Technologies, the tech-transfer arm of Michigan State University, where she was appointed director in late March (see BTW, 4/2/2007). She decided to leave MSU Technologies for undisclosed reasons.
Prior to that, Kuuttila had directed STC.UNM since June 2003. Kuuttila has also served as assistant vice president for technology commercialization at Purdue Research Foundation; director of technology commercialization at University of Georgia; and director of the Office of Technology Commercialization at the Center for Advanced Technology Development at Iowa State University. She holds a master’s degree in public administration from Iowa State University, and a BS in electrical engineering from the University of Michigan.

Arizona State University last week said that it has named Augustine Cheng as managing director of Arizona Technology Enterprise, the school’s tech-transfer arm, effective Aug. 1.
Cheng will replace Peter Slate, who stepped down as president and chief executive of AzTE in March.
Cheng will join AzTE from Columbia University, where he serves as associate general counsel of Columbia’s Patent and Licensing Group. He has been with Columbia since 1984 after working as an intellectual property attorney for New York-based law firms Cravath Swaine & Moore and Schulte Roth & Zabe for four years. He holds a jurist JD from Fordham Law School, and has served as associate editor of Fordham Law Review.

Paul Silber has been named chair of the Greater Baltimore Technology Council's Biotech Roundtable. Silber was the founder, former president and CEO of In Vitro Technologies, a leading US contract-testing laboratory for in vitro testing services and products, before being acquired last year for $30 million by British-owned Celsis.
The GBTC Biotech Roundtable promotes the growth of biotechnology companies in the Greater Baltimore region. The Roundtable provides mentoring and networking opportunities to its members, and works to identify critical success factors necessary for the growth of life sciences businesses in the Baltimore region.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.